Metformin and Autoimmunity: A “New Deal” of an Old Drug
Metformin (dimethyl biguanide) is a synthetic derivative of guanidine, isolated from the extracts of Galega officinalis, a plant with a prominent antidiabetic effect. Since its discovery more than 50 years ago, metformin represents a worldwide milestone in treatment of patients with type 2 diabetes...
Main Authors: | Francesco Ursini, Emilio Russo, Gianluca Pellino, Salvatore D’Angelo, Agostino Chiaravalloti, Giovambattista De Sarro, Roberto Manfredini, Roberto De Giorgio |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.01236/full |
Similar Items
-
Impaired Gonadotropin-Lowering Effects of Metformin in Postmenopausal Women with Autoimmune Thyroiditis: A Pilot Study
by: Robert Krysiak, et al.
Published: (2023-06-01) -
Reduced Mortality Associated With the Use of Metformin Among Patients With Autoimmune Diseases
by: Chun-Yu Lin, et al.
Published: (2021-04-01) -
Metformin: A Potential Therapeutic Tool for Rheumatologists
by: Teresa Salvatore, et al.
Published: (2020-09-01) -
Autoimmune ear disease: clinical and diagnostic relevance in Cogan’s sydrome
by: Luigi Maiolino, et al.
Published: (2017-03-01) -
Neutrophilic Dermatoses in Autoimmune Diseases: Report of Two Cases Associated with Autoimmune Thyroiditis
by: Angelo Cassisa
Published: (2018-02-01)